Lilly Launches Diabetes Prevention and Management Pilot in Indianapolis Neighbourhoods
4 May 2018 - - Indianapolis, Indiana-based global pharmaceuticals specialist Eli Lilly and Company (NYSE: LLY) and Indiana University's (IU's) Richard M. Fairbanks School of Public Health at Indiana University–Purdue University Indianapolis (IUPUI) have launched a new neighbourhood-based, data-driven pilot in Indianapolis to help address the high incidence of diabetes, the company said.
The USD7 m, five-year program will focus on three Indianapolis neighborhoods with significant health disparities and high rates of diabetes and where life expectancy can be 14 years lower than in other neighborhoods
The pilot will target people with diabetes or at risk for the disease. The three communities were selected based on high prevalence of diabetes, socio-economic factors, and highly engaged community members and organizations.
Lilly and IU's Fairbanks School of Public Health at IUPUI are implementing the pilot with Eskenazi Health, Local Initiatives Support Corp.
Indianapolis, and the Marion County Public Health Department. The pilot will deploy a model that uses newly hired community health care workers to help identify people with diabetes and connect them with quality care.
In addition, community members will help identify and propose solutions for cultural, social, environmental, economic and policy barriers that increase the risk for diabetes, such as the lack of healthy food options and public spaces for exercise.
Lilly employees work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to communities through philanthropy and volunteerism.
The IU Richard M. Fairbanks School of Public Health is committed to advancing the public's health and well-being through education, innovation, and leadership through biostatistics, epidemiology, cancer research, community health, environmental public health, health policy and health administration.